Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.170
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.189
+0.019 (1.64%)
After-hours: Mar 9, 2026, 7:49 PM EDT
Vivani Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
93.43M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVANI News
- 5 weeks ago - Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 - GlobeNewsWire
- 5 weeks ago - Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewsWire
- 6 weeks ago - Vivani Medical, Inc. Announces Pricing of Common Stock Offering - GlobeNewsWire
- 4 months ago - Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewsWire
- 5 months ago - Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 - GlobeNewsWire
- 6 months ago - Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewsWire
- 6 months ago - Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management - GlobeNewsWire